Cargando…
Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
Treatment with 5α‐reductase inhibitors has been associated with sexual adverse events such as impotence (erectile dysfunction) and decreased libido. The primary objective of this study was to evaluate adverse events related to sexual function, based on their frequency, duration, persistence and asso...
Autores principales: | Tsai, Tsen‐Fang, Choi, Gwang Seong, Kim, Beom Joon, Kim, Moon‐Bum, Ng, Chi Fai, Kochhar, Puja, Jasper, Stacy, Brotherton, Betsy, Orban, Barbara, Lulic, Zrinka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055634/ https://www.ncbi.nlm.nih.gov/pubmed/29667763 http://dx.doi.org/10.1111/1346-8138.14329 |
Ejemplares similares
-
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017) -
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
por: Choi, Gwang Seong, et al.
Publicado: (2016) -
Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
por: Rhie, Arang, et al.
Publicado: (2019) -
Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023) -
Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia–Pacific and Latin America
por: Lulic, Zrinka, et al.
Publicado: (2017)